EAM
IBB icon

Erste Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Erste Asset Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.3M Hold
102,330
– – 0.13% 157
2026
Q1 		$17.3M Hold
102,330
– – 0.16% 140
2025
Q4 		$17.3M Buy
102,330
+37,860
+59% +$6.15M 0.15% 144
2025
Q3 		$9.31M Buy
64,470
+370
+0.6% +$50.5K 0.09% 193
2025
Q2 		$8.11M Buy
64,100
+1,100
+2% +$135K 0.07% 222
2025
Q1 		$347K Buy
63,000
+24,000
+62% +$3.25M ﹤0.01% 451
2024
Q4 		$211K Hold
39,000
– – ﹤0.01% 484
2024
Q3 		$5.68M Buy
+39,000
New +$5.64M 0.07% 233
2023
Q3 		– Sell
-43,171
Closed -$5.44M – 562
2023
Q2 		$5.44M Sell
43,171
-64
-0.1% -$8.31K 0.1% 207
2023
Q1 		$5.5M Buy
+43,235
New +$5.66M 0.11% 198
2022
Q4 		– Sell
-43,576
Closed -$5.1M – 582
2022
Q3 		$5.1M Sell
43,576
-34
-0.1% -$4.22K 0.11% 199
2022
Q2 		$5.15M Hold
43,610
– – 0.11% 198
2022
Q1 		$5.68M Sell
43,610
-13,785
-24% -$1.8M 0.11% 202
2021
Q4 		$8.83M Sell
57,395
-1,123
-2% -$174K 0.16% 155
2021
Q3 		$9.46M Hold
58,518
– – 0.19% 138
2021
Q2 		$9.58M Buy
58,518
+9,688
+20% +$1.49M 0.19% 138
2021
Q1 		$7.35M Buy
48,830
+39,830
+443% +$6.33M 0.18% 148
2020
Q4 		$1.37M Hold
9,000
– – 0.04% 306
2020
Q3 		$1.22M Hold
9,000
– – 0.04% 292
2020
Q2 		$1.23M Hold
9,000
– – 0.05% 278
2020
Q1 		$970K Hold
9,000
– – 0.06% 258
2019
Q4 		$1.08M Sell
9,000
-18,251
-67% -$2.04M 0.05% 277
2019
Q3 		$2.71M Buy
+27,251
New +$2.85M 0.14% 154
2019
Q2 		– Sell
-1,254
Closed -$140K – 431
2019
Q1 		$140K Hold
1,254
– – 0.01% 370
2018
Q4 		$119K Buy
+1,254
New +$133K 0.01% 389

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Erste Asset Management's IBB Position: Q2 2026 in Review

Erste Asset Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 102,330 shares worth $17.3M. The position accounts for 0.13% of the portfolio, ranked #157.

Erste Asset Management first reported a position in IBB in Q4 2018 and has held it in 25 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Erste Asset Management held 102,330 shares of iShares Biotechnology ETF worth $17.3M as of Q2 2026.
  • Erste Asset Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.13% of Erste Asset Management's portfolio in Q2 2026, its #157 holding.
  • Erste Asset Management first reported a position in iShares Biotechnology ETF in Q4 2018 and has held it in 25 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.